The Centers for Medicare & Medicaid Services has temporarily disabled access to electronic clinical quality measure Submission Summary and Performance Summary reports at the QualityNet secure portal to alleviate very slow processing times for Electronic Health Record Hospital Reports related to eCQMs. Effective March 3, pending requests for these reports will no longer display in the report queue, the agency said. Hospitals, critical access hospitals and their vendors should use the eCQM Submission Status Report (R530) to confirm program status for eCQM submissions, and regenerate the report after changes to obtain the most current status. The report should indicate “Y” for the Successful MU Submission field and Successful IQR-EHR Submission field to signal successful electronic reporting. CMS anticipates that access to the eCQM Submission Summary and Performance Summary reports will resume after the close of the eCQM submission period on March 13 at 11:59 p.m. Pacific Time. For further assistance, contact the Hospital Inpatient Value, Incentives, and Quality Reporting Outreach and Education Support Team at https://cms-ip.custhelp.com or (844) 472-4477.

Related News Articles

Headline
The White House Dec. 11 issued an executive order to establish a national artificial intelligence framework to preempt state regulation. The order calls for…
Headline
John Pastor, president of Fairview Pharmacy Services and chief operating officer of Fairview Pharmacy Solutions, shares how M Health Fairview’s expansive…
Headline
U.S. and international agencies Dec. 3 released guidance on integrating artificial intelligence into operational technology. The guidance is intended to…
Headline
The Food and Drug Administration announced Dec. 5 that it will launch the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or…
Headline
The Department of Health and Human Services Dec. 4 released its strategy on integrating artificial intelligence across internal operations, research and public…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…